(2S,2'S,2''S)-N,N',N''-((4S,4'S,4''S,7S,7'S,7''S)-20,20',20''-((2S,5S,10S)-7,12-dioxo-1,4,8-triazacyclododecane-2,5,10-triyl)tris(4,7-bis(4-hydroxybenzyl)-2,5,8,15-tetraoxo-3'',6'',9'',16''-tetraazaicosane-20,1-diyl))tris(2,6-diaminohexanamide)

ID: ALA1241018

Chembl Id: CHEMBL1241018

PubChem CID: 52946800

Max Phase: Preclinical

Molecular Formula: C117H176N24O23

Molecular Weight: 2286.84

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  NCCCC[C@H](N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCCCCCC(=O)NCCCC[C@@H]1CNC(=O)C[C@H](CCCCNC(=O)CCCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CNC(=O)[C@@H](N)CCCCN)NC[C@H](CCCCNC(=O)CCCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CNC(=O)[C@@H](N)CCCCN)NC(=O)C1

Standard InChI:  InChI=1S/C117H176N24O23/c118-55-13-7-25-92(121)109(156)132-74-106(153)136-98(67-80-37-49-89(145)50-38-80)115(162)139-95(64-77-31-43-86(142)44-32-77)112(159)127-61-16-1-4-28-101(148)124-58-19-10-22-83-70-105(152)135-85(24-12-21-60-126-103(150)30-6-3-18-63-129-114(161)97(66-79-35-47-88(144)48-36-79)141-117(164)100(69-82-41-53-91(147)54-42-82)138-108(155)76-134-111(158)94(123)27-9-15-57-120)73-130-84(71-104(151)131-72-83)23-11-20-59-125-102(149)29-5-2-17-62-128-113(160)96(65-78-33-45-87(143)46-34-78)140-116(163)99(68-81-39-51-90(146)52-40-81)137-107(154)75-133-110(157)93(122)26-8-14-56-119/h31-54,83-85,92-100,130,142-147H,1-30,55-76,118-123H2,(H,124,148)(H,125,149)(H,126,150)(H,127,159)(H,128,160)(H,129,161)(H,131,151)(H,132,156)(H,133,157)(H,134,158)(H,135,152)(H,136,153)(H,137,154)(H,138,155)(H,139,162)(H,140,163)(H,141,164)/t83-,84-,85-,92-,93-,94-,95-,96-,97-,98-,99-,100-/m0/s1

Standard InChI Key:  XPUDFSGPDFDLMZ-QCEZFXFPSA-N

Alternative Forms

1. Parent:

   

   ALA1241018

   (2S)-2,6-diamino-N-[2-[[(2S)-1-[[(2S)-1-[[6-[4-[(2S,5S,10S)-2,5-bis[4-[6-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2,6-diaminohexanoyl]amino]acetyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]hexanoylamino]butyl]-7,12-dioxo-1,4,8-tria

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 2286.84

Molecular Weight (Monoisotopic): 2285.3340

AlogP: ┄

#Rotatable Bonds: ┄

Polar Surface Area: ┄

Molecular Species: ┄

HBA: ┄

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): ┄

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: ┄

CX LogD: ┄

Aromatic Rings: ┄

Heavy Atoms: ┄

QED Weighted: ┄

Np Likeness Score: ┄

References

1. Fournel S, Wieckowski S, Sun W, Trouche N, Dumortier H, Bianco A, Chaloin O, Habib M, Peter JC, Schneider P, Vray B, Toes RE, Offringa R, Melief CJ, Hoebeke J, Guichard G..  (2005)  C3-symmetric peptide scaffolds are functional mimetics of trimeric CD40L.,  1  (7): [PMID:16370373] [10.1038/nchembio746]

Source

Source(1):

• Scientific Literature